Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Author/Clinician Announces New Game-Changing Strategies for Terminal Cancer Patients
  • USA - English


News provided by

LifelinesToCancerSurvival.com

Dec 09, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

Mark Roby was diagnosed with one of the world's rarest cancers in 2002, and given four months to live. Today he's alive and well.

Post this

Birmingham, MI (PRWEB) December 09, 2015 -- Each day in the United States, close to 1600 children and adults – enough to fill four jumbo jets - die of cancer. More than 4000 are newly diagnosed.

Mark Roby was almost one of those fatal statistics.

But he beat the odds. Roby's new book, "Lifelines to Cancer Survival," is a one-of-a-kind guide that offers patients cutting-edge, novel approaches to personalizing their own care. Diagnosed with one of the world’s rarest cancers (liver and lungs) in 2002, Roby was given four months to live. He visited oncologists around the country and they all told him to enjoy whatever time he had left. He has done everything he can to prove those doctors wrong—and today he’s alive and well. He put what he learned in his book.

“I was told I could either do nothing, or receive very high doses of interferon, a very potent chemotherapy, as palliative care. That was the standard of care,” says Roby.

He went for the chemo and ended up in the hospital with severe side effects. The drug didn’t work. “As a medical professional myself, I realized I would have to redefine and rethink what I would need to do in order to survive,” says Roby.

And survive he has. But how? Why is his story different from the countless others diagnosed with terminal cancer?

ROBY DISCOVERED PERSONALIZED CARE
His first turning point came when he met with a researcher/oncologist at MD Anderson in Houston, Texas for a consult. The researcher advised Roby that to stay alive, he would have to go beyond the standard of care. Roby would need to:

• Make survival his priority, including researching his own tumor
• Create three contingency plans to have on the table at all times
• Use advanced biomarkers to guide his treatment

So, first he took charge of his own care, becoming an incessant researcher himself and enlisting the aid of whomever would help him.

Secondly, having three backup plans reduced some of Roby’s anxiety by knowing what he could try next, instead of scrambling when some treatment didn’t work. As part of this “Triad of Survival,” Roby searched for novel cancer treatments based on his own tumor’s makeup, and pushed for their use. If the doctors he was seeing didn’t approve, he found someone who did. There were new drugs, clinical trials and even foreign chemotherapy, illegal in the United States. Some worked, and some did not, yet Roby continued his quest.

Thirdly, Roby used blood and genetic biomarkers (such as VEGF/angiogenesis, inflammatory markers, and molecular growth pathways) to help doctors guide his treatment.

After a liver transplant, Roby’s cancer returned. He went to Boston for a molecular profile of the tumor, a test he had been told for years would be a waste of time and money. He was put on a new drug targeting the tumor’s genetic pathway to stop further growth.

“There were three genetic abnormalities,” Roby explains. “I asked my team at Cleveland Clinic to target the main one, and I’ve been good ever since. They took my research seriously.”

GAME CHANGER FOR CANCER PATIENTS
"Lifelines to Cancer Survival" arms patients with novel options for survival, much different than what most medical centers are offering. In it, Roby provides critical, cutting-edge information for cancer patients, including strategies, websites, labs that perform advanced testing, and a list of eclectic oncologists.

“It’s about survival,” Roby states. “I wrote the book because there are lots of different ways to fight different malignancies and nobody knows about them. It’s a guide that will help cancer patients find safe, more effective care.”
______________________________________________________________________________
Mark Roby is a certified physician assistant, naturopath, cancer strategist and speaker. He is the cofounder of the Metro Detroit Center for Attitudinal Healing. He is also author of the new book Lifelines to Cancer Survival: A New Approach to Personalized Care. He can be contacted through his website (http://www.LifelinestoCancerSurvival.com) or at 248-318-8775.

# # #

Mark Roby, PA-C, LifelinesToCancerSurvival.com, http://www.lifelinestocancersurvival.com/about/robys-top-ten-keys/, +1 248-318-8775, [email protected]

Modal title

Mark Roby's Top Ten Keys For Cancer Survival
Mark Roby's Top Ten Keys For Cancer Survival
Mark Roby
Mark Roby
Mark Roby's Top Ten Keys For Cancer Survival Mark Roby

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.